Watch a seminar by Immunovative's founder, CEO and inventor of Mirror Effect technology presented to an private audience by invitation only at the Montreal University Club. In this seminar, Dr. Har-Noy describes the current status of the war against cancer and how immunotherapy in general and AlloStim in particular can make a difference in the life's of cancer patients. This seminar was conducted in 2012 before the wave of new immunotherapy drugs were approved by the US FDA.
Cancer immunotherapy holds out great promise, but good animal results have not been successfully translated to the clinic. This re-evaluation brings forward new ideas are about immune responses in cancer patients that may improve strategies in future.